baber/WOPTO huggingface dataset:
Patent IE-38734-L (IE)
Title: Thiadiazolyl-hydroxyhydantoins; herbicides
IPC: B01J25/00
Filed: 1974-01-11
Abstract: 1445912 3 - (1,3,4 - Thiadiazol - 2 - yl) - 5- hydroxy-hydantoins BAYER AG 11 Jan 1974 [13 Jan 1973] 01373 Heading C2C Compounds of Formula I wherein R represents alkyl, haloalkyl, alkyl mercapto or alkylsulphonyl and R<SP>1</SP> represents alkyl are prepared by reacting (e.g. at - 20‹ to +20‹ C.) a parabamic acid derivative of Formula II with H 2 in the presence of a hydrogenation catalyst, or with a hydrogen donor (e.g. NaBH 4 , LiAlR 4 ) in the presence of a polar solvent. The compounds of Formula I in which R represents alkyl or C 2-4 alkylmercapto are novel and are claimed per se. Exemplified compounds of Formula I are those in which R<SP>1</SP> is CH 3 or C 2 H 5 and R is t-C 4 H 9 , CF 3 , CH 3 S-, C 2 H 5 S-, n-C 3 H 7 S-, i-C 3 H 7 S-, n-C 4 H 9 S-, or CH 3 SO 2 -. The starting materials of Formula II wherein R<SP>1</SP> is CH 3 and R is t-C 4 H 9 or C 2 H 5 -S- are prepared from oxalyl chloride and the corresponding 1 - methyl - 3 - (1,3,4 - thiadiazol - 2- yl)-urea. The compounds of Formula I are herbicides.
[GB1445912A]
Patent IE-33951-L (IE)
Title: Envelope detacher apparatus
IPC: B31B70/00
Filed: 1970-01-20
Abstract: 1,251,110. Delivering sheets. LAMSON PARAGON Ltd. 12 Dec., 1969 [27 Jan., 1969], No. 60642/69. Heading B8R. [Also in Division B6] Strippers.-Envelopes 35 are stripped from a carrier web 34 by a stripper blade 16, the web being drawn through the apparatus by rollers 31, 32 and the envelopes being delivered into a receiver 11. Flanges 24 pass between the edges of the web and those of the envelopes and guide the assembly to the stripping station. A plate carried on pivoted wire support 18 ensures orderly delivery into the receiver 11. (From GB1251110 A) [FR2029453A1]
Patent IE-36073-L (IE)
Title: Heterocyclic benzenesulphonyl ureas
IPC: C07D209/40
Filed: 1972-02-10
Abstract: 1329812 Sulphonyl-semicarbazides SCIENCE UNION ET CIE SOC FRANCAISE DE RECHERCHE MEDICALE 2 Feb 1972 [15 Feb 1971] 4638/71 Heading C2C Novel compounds (I) (including salts thereof) where Het signifies indolinyl, isoindolinyl, hexahydroindolinyl, 4,7-endoalkylene-tetra- or -hexahydroisoindolinyl, 4,7-endoxo-hexahydroisoindolinyl, tetra- or deca-hydroquinolyl or -hydroisoquinolyl, aza-bicyclo[3,10]hexyl, aza-bicyclo- [3,2,0]heptyl, aza - bicyclo[3,3,0]octyl, azabicyclo[2,2,2]octyl, aza - bicyclo[3,2,1]octyl, aza-bicyclo[4,3,0]-nonyl or -nonenyl, azabicyclo[3,2,2]nonyl or aza-bicyclo[3,3,1]nonyl bonded via their nitrogen atom, are made by reacting KO 2 C.C 6 H 4 .SO 2 .NHK with Het- NH.CO.NPh 2 and, if desired, acidifying the product obtained. Pharmaceutical preparations especially showing microcirculation-improving, fibrinolytic- and platelet-adhesiveness and aggregation-decreasing properties contain (I) as active ingredient. Administration may be orally, rectally or parenterally.
[GB1329812A]
Patent IE-830179-L (IE)
Title: Temperature responsive pacifier assembly
IPC: G01K13/00
Filed: 1983-01-31
Abstract: There is disclosed a novel temperature responsive pacifier assembly (10) comprised of a liquid crystal material responsive to a temperature above about 37.8°C (100°F) whereby the liquid crystal material (28) changes color to visuably indicate an abnormal temperature condition of an individual utilizing the pacifier assembly, as well as a process for manufacture same.
Patent IE-780215-L (IE)
Title: Electromechanical display device
IPC: G09F9/30
Filed: 1978-02-01
Abstract: An electromechanical digital indicator for displaying numerical information is disclosed, in which the angular movements of seven movable segments, combined with the action of a block in the shape of an eight and made of a transparent and light-channelling plastics material, acts in such a way as to display any figure at choice from zero to nine in solid lines rather than in segmental form, contrary to what occurs with the conventional display devices. Fluorescent layers on the bottom wall of the block and other expedient render the display visible under any conditions of direct or indirect lighting and also in the darkness of the night. Internal illumination means can be provided in the inside of the indicator box, that which could not be obtained heretofore with the electromechanical digital display appliances.
[US4161832A]
Patent IE-890343-L (IE)
Title: Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
IPC: A61K49/22
Filed: 1989-02-03
Abstract: The invention relates to gas- or liquid-containing microparticles based on amyloses, process for producing them and their use as diagnostic agents.
Patent IE-800858-L (IE)
Title: Babesiosis antigen.
IPC: A61K39/018
Filed: 1980-04-28
Abstract: Soluble antigen, specific for Babesia parasites, is isolated from growth media of Babesia-infected erythrocytes in cell culture and characterized, inter alia, by its ability to inhibit the capacity of specific Babesia serum antibodies to neutralize infectivity of Babesia merozoites in vitro. Antigen preparations provide immunologically active components useful for vaccination of animals against infection by Babesia parasites and may be employed in the preparation of diagnostic reagents.
[US4596707A]
Patent FI-803974-L (FI)
Inventor: MAYER HELMUT
IPC: F16L3/22
Filed: 1980-12-19
Abstract: 1. A support (10) for a radiator comprising a plate (14) adapted to rest against a wall plug (54) or to be attached thereto, a counter-piece (26) and a screw (44) extending through the plate (14) and the counter-piece (26), the counter-piece (26) including a bridge (40) resting againts the plate (14), and two spreading jaws (28) connected with each other by means of the bridge (40), said spreading jaws receiving between each other a spreading member (60) disposed on the screw (44) and being adapted to be spread away from each other towards adjacent radiator tubes or ribs, in response to tightening of the screw (44) characterized in that the spreading member (60) has a through hole (62) in which the screw (44) is slidable in longitudinal direction, and the spreading member (60) has furthermore, at its side averted from the plate (14), a longitudinal slot (66) disposed in the center plane between the two spreading jaws (28) and may be spread upon tightening of the screw (44) by virtue of the head (16) thereof penetrating the spreading member (60).
Patent FI-812614-L (FI)
Inventor: MILLER WALTER L
IPC: C12N15/71
Filed: 1981-08-25
Abstract: A DNA transfer vector comprises a deoxynucleotide sequence coding for bovine growth hormone or bovine pre-growth hormone.
Patent FI-813263-L (FI)
Inventor: PALL DAVID B
IPC: B32B27/34
Filed: 1981-10-19
Abstract: A process is provided for preparing skinless liquophilic alcohol-insoluble polyamide membranes by preparing at a first temperature a solution in a polyamide solvent having a temperature coefficient of solubility within the range from about 0.01 to about 5 weight per cent per degree Centrigrade of on alcohol-insoluble polyamide resin having a ratio CH2:NHCO of methylene CH2 to amide NHCO groups within the range from about 7:1 to about 12:1; inducing nucleation of the solution by controlled addition to the solution of a nonsolvent for the polyamide resin, under controlled conditions of concentration, temperature, addition rate, and degree of agitation to obtain a visible precipitate of polyamide resin particles which may or may not thereafter partially or completely redissolve, thereby forming a casting solution; spreading the casting solution on a substrate to form a thin film thereof on the substrate; cooling the film of casting solution to a second temperature sufficiently lower than the first temperature to precipitate polyamide resin from the casting solution; contacting and diluting the film of casting solution with a nonsolvent liquid, preferably containing a substantial proportion of the solvent liquid but less than the proportion in the casting solution, to precipitate polyamide resin from the casting solution in the form of a thin skinless liquophilic membrane; and washing and drying the resulting membrane; the alcohol-insoluble polyamide membranes obtained by this process have the unusual property of being liquophilic, i.e., readily wetted by organic liquids having a surface tension below about 60 dynes/cm, while being substantially not wetted by water, have absolute particle removal capabilities of the order of 0.1 to 5  mu M or more, and are useful as filter media for liquid systems in which such organic liquids are the continuous phase, as well as for separating immiscible liquid mixtures containing such liquids and liquids having a higher surface tension such as water.
Patent FI-824165-L (FI)
Inventor: GAINO MITSUNORI
IPC: C07D281/10
Filed: 1982-12-03
Abstract: A benzothiazepine derivative of the formula:   <IMAGE> (I)  wherein R is hydrogen or acetyl, is prepared by condensing a compound of the formula:   <IMAGE> (II)  wherein R is the same as defined above, with 2-(diamethylamino)ethyl halide (i) in the presence of potassium hydroxide in acetone; or (ii) in the presence of potassium carbonate in acetone, lower alkyl acetate, a mixture of acetone and water or a mixture of lower alkyl acetate and water.
Patent FI-832490-L (FI)
Inventor: UEDA IKUO
IPC: C07D213/30
Filed: 1983-07-07
Abstract: A pyridylalkyl nitrate compound of the formula: 
<CHEM>
 wherein R<1> is hydrogen, lower alkyl, halogen or nitroxy(lower)alkyl,
 one of R<2> and R<3> is mono (or di)-nitroxy(lower)-alkyl and the other of R<2> and R<3> is hydrogen or halogen,
 and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient.
Patent FI-852135-L (FI)
Inventor: MARKUSSEN JAN
IPC: C12N15/69
Filed: 1985-05-29
Abstract: Human insulin precursors containing the peptide chain B(1-29)-A(1-21) of human insulin and derivatives thereof with a bridging chain connecting the carboxyl terminus of the B(1-29)- chain with the amino terminus of the A(1-21 )-chain are prepared by culturing a yeast host transformed with a replicable expression vehicle capable of expressing a DNA- sequence encoding the insulin precursor. The bridging chain is preferably relatively short and contains preferably from 2 to 8 amino acid residues. The bridging chain must not contain two adjacent basic amino acid residues (Lys or Arg) and has one Lys or Arg connected to the amino terminus of the (A(1-21)- chain. Human insulin is prepared from the insulin precursors by in vitro conversion.
Patent IE-841046-L (IE)
Title: 5-acyl-2-(1h)-pyridinones.
IPC: C07D401/10
Filed: 1984-04-27
Abstract: Novel 5-acyl-2-(1H)pyridinones and their use as cardiotonic agents. Typical of the compounds is 5-acetyl-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarbonitrile which is prepared by condensing anionic cyano acetamide with 3-[(dimethylamino)methylenyl]-2,4-pentanedione in an inert organic solvent.
[US4568751A]
Patent IE-841114-L (IE)
Title: Absorbent product
IPC: D21C9/00
Filed: 1984-05-04
Abstract: An absorbent retentive cellulosic pulp comprising sheets or platelets (10) of microfibrils (12), said sheet-like particles (10) being of random shape and forming discontinuous walls surrounding voids (14), is provided by extensively beating a dilute aqueous dispersion of cellulose fibres and then freeze-drying the beaten pulp. 
<??>The pulp so treated is suitable for use in products such as sanitary napkins, tampons, diapers, dressings or the like which are used to absorb body fluids.
Patent IE-851144-L (IE)
Title: Process for forming ic wafer with buried zener diode¹¹zener diode
IPC: H01L29/866
Filed: 1985-05-08
Abstract: A new process making it possible to produce stable buried Zener diodes in large-sized wafers where slow ramping of diffusion temperatures is required to avoid crystal damage and other adverse effects. The process includes an initial deep ion implantation of p type dopant (boron). A second ion implantation of n type dopant (arsenic) is made over the p type implantation. Both implantations are driven in to the required degree. An additional p type dopant diffusion is made coincident with the base formation by ion implantation to establish connection to the original deep p-doped region, and an additional n type dopant diffusion is made coincident with the emitter formation to establish connection with the n type dopant implantation.
[EP0160919A2]
Patent IE-801340-L (IE)
Title: Immunostimulant tripeptides
IPC: A61P31/04
Filed: 1980-06-27
Abstract: Tripeptides of the general formula: <IMAGE> II wherein the symbols R, which may be the same or different represent hydrogen or a fatty acid residue (at least one of them representing a fatty acid residue), R1 represents hydroxy, amino or alkoxy and R2 and R3, which may be the same or different, represent hydrogen, carboxy, carbamoyl or alkoxycarbonyl radical (with the proviso that R2 and R3 cannot simultaneously represent a hydrogen atom), the alanine moiety being in the L form, the glutamic acid moiety being in the D form, the lysine moiety (when R2 or R3=a hydrogen atom) being in the L form and the 2,6-diaminopimelic acid moiety or its derivatives (when R2 and/or R3=carboxy, carbamoyl or alkoxycarbonyl) being in the D,D, L,L, D,D/L,L (racemic) or D,L (meso) form, and salts thereof, possess immunological adjuvant and immunostimulant activity.
[US4916119A]
Patent IE-41564-L (IE)
Title: Ergot peptide alkaloids
IPC: C07D498/14
Filed: 1975-06-19
Abstract: 1499420 9,10-Dihydroergopeptine derivatives SANDOZ Ltd 16 June 1975 [21 June 1974] 25527/75 Heading C2C Novel compounds of the Formula I wherein R 1 is C 2-5 alkyl and R 2 is methyl or ethyl and acid addition salts thereof may be prepared by condensing a functional derivative of a compound II with an acid addition salt of a compound III 6 - Nor - 6 - isopropyl - 9,10 - dihydrolysergic acid is prepared by N-alkylation of 6-nor-9,10- dihydrolysergic acid methyl ester, followed by saponification of the ester. Its acid choride is formed in situ using oxalyl chloride. Pharmaceutical compositions of the compounds I with the usual excipients show vasoconstricter activity.
[GB1499420A]
Patent IE-861484-L (IE)
Title: Fluid flow control system and connecting fitting therefor
IPC: A61B17/00
Filed: 1986-06-04
Abstract: A fluid flow control apparatus specially adapted for use with an ultrasonic surgical tool (52) which provides for irrigation of a surgical site and for aspirating fluid from the site comprises a source of irrigation fluid (102), an irrigation fluid conduit (104) for conducting the irrigation fluid to a surgical site, an aspiration fluid conduit (54) for conducting fluid away from the surgical site, a suction pump (112) connected to the aspiration site, a pressure-sensitive control system (120) for removing the source of suction from the aspiration conduit when a predetermined value of suction is exceeded, and a valve (132) for controllably admitting irrigation fluid into the aspiration fluid conduit. A check valve (109) in the irrigation conduit prevents a reverse surge when the irrigation fluid is admitted to the aspiration conduit. A modified T connector (400) with a first fluid conduit (402) having a male connector end (406) and a female connector end (404). A second rigid tubular member (408) in fluid communication with the first conduit (402) has a third rigid member (414) a right first angles to the second rigid member (408) and is parallel to the first fluid conduit (402).
[WO8607249A1]
Patent IE-861497-L (IE)
Title: Hair styling mousse
IPC: A61K8/891
Filed: 1986-06-05
Abstract: Aqueous aerosol mousse compositions are disclosed which contain a silicone material dissolved in the aerosol propellant phase. Such compositions are not only easily processed but also provide for better dry combing than is obtainable if the silicone material is dispersed in the aqueous phase.
[EP0205306A2]
Patent IE-41679-L (IE)
Title: Rotary kiln
IPC: F27B7/28
Filed: 1975-09-09
Abstract: The kiln comprises a slowly rotating drying-kiln section and a relatively quickly rotating kiln-section, a transition zone being arranged in the middle of the kiln. The transition zone comprises shovel-shaped bricks and intermediate bricks. The shovel-shaped bricks comprise projecting portions provided with especially shaped surfaces.
[US4029464A]
Patent IE-40452-L (IE)
Title: Forming impressions in cigarette filters.
IPC: A24D3/02
Filed: 1974-12-18
Abstract: This invention relates to a method and apparatus for forming cigarette filters, including a means for receiving and holding a plurality of filters and a heated probe which can be moved into contact with the filters to form the filters into a desired configuration.
[US3958498A]
Patent IE-892685-L (IE)
Title: Preparation comprising cavitate- or clathrate-forming¹host/guest complexes as contrast agent
IPC: A61K49/00
Filed: 1989-08-22
Abstract: The invention relates to the use of cavity- or clathrate-forming host/guest complexes as contrast media in ultrasonic, X-ray or NMR investigations.
[EP0357163A1]
Patent IE-822744-L (IE)
Title: Cold water curable orthopedic cast
IPC: A61F/
Filed: 1982-11-17
Abstract: A bandage material for forming in place an orthopedic cast comprising a pliant, large mesh fabric carrier formed from a knit of a high-strength, high-modulus yarn with a low moisture pick-up, the fabric carrier having openings of relatively large transverse dimension, and being coated with a polymer composition comprising a cold water curable polyurethane prepolymer comprising the reaction product of a polyalkylene ether diol, a polyalkylene ether triol and a diisocyanate.
Patent IE-812770-L (IE)
Title: 5-(AMINOALKYL)-11-PHENYL-5H-DIBENZO £b,e|£1,4| DIAZEPINES
IPC: C07D243/38
Filed: 1981-11-25
Abstract: 5-(Aminoalkyl)-11-phenyl-5H-dibenzo [b,e][1,4]diazepines having the formula: <IMAGE> (wherein R<1> and R<2> each represent a hydrogen atom or a methyl group and X represents a hydrogen, chlorine, bromine or fluorine atom) and their salts are antidepressants.
[GB2106894A]
Patent IE-813048-L (IE)
Title: Transforming solid waste into fibrous material
IPC: B03B9/06
Filed: 1981-12-23
Abstract: In order to avoid producing any secondary waste in the production of a fibrous and a granular material from household, agricultural, forestry waste, organic waste of the manufacturing and/or service industries, the primary waste first undergoes an opening treatment in an opening unit and then, after removal of any metallic components by magnetic separation units, is divided into three fractions. Such division is effected by a fractioning unit into (a) a fine fraction not exceeding the required final product particle size, (b) a coarse fraction easy to process mechanically, and (c) a coarse fraction difficult to process mechanically. The two coarse fractions are then separately reduced to the required final product particle size in reducing unit optimally suited to the particular coarse fraction. Then all three fractions are re-united and dried to a specific maximum residual moisture content and sterilized in a drying unit by heating and extraction of the resultant steam, and are jointly fractionated by a further fractionating unit and air separators into a heavy fraction consisting chiefly of inorganic granulate, a light fraction consisting chiefly of organic fibres, and a dust fraction consisting chiefly of organic dust particles.
[US4623515A]
Patent IE-883390-L (IE)
Title: Pharmaceutical compositions
IPC: A61K47/26
Filed: 1988-11-11
Abstract: The invention relates to pharmaceutical compositions comprising calcitonin and a glycyrrhizinate absorption enhancer. Preferred compositions are those adapted for nasal administration, for example nasal sprays.
[EP0327756A2]
Patent NO-753441-L (NO)
Inventor: RIEBEL H J
IPC: A01P7/04
Filed: 1975-10-10
Abstract: 'Pyrimidinyl(tiono)(tiol)fos for(fosfon)-syreestere resp. -esteramider samt deres anvendelse som insekticider, akaricider og nemåticider.
Patent NO-841010-L (NO)
Inventor: PANDIT NEVEDITA
IPC: A61K31/00
Filed: 1984-03-15
Abstract: Water-soluble dispersions of chlorthalidone are prepared by a process comprising: (a) forming a solution comprising a water soluble pharmaceutically acceptable polymeric carrier and a C1-C4 alkanol,  (b) dissolving chlorthalidone in the solution thus formed, and  (c) removing the C1-C4 alkanol from the solution by evaporation, the amount of said carrier being effective to suppress substantially the formation of the alkyl ether by-product from the reaction of chlorthalidone with the C1-C4 alkanol. A preferred water soluble carrier is polyvinylpyrrolidon and a preferred C1-C4 alkanol is methanol.
Patent NO-850930-L (NO)
Inventor: TROGISCH GUENTER
IPC: H05K3/00
Filed: 1985-03-08
Abstract: A multi-layer through-hole contacted flexible circuit board and method of manufacture thereof is presented having a laminar construction which is strictly symmetrical in the bending area; and which have no exposed adhesive. Registration holes are first introduced in a copper-laminated base material, then, avoiding the bending area, with the aid of the registration holes, an adhesive layer is applied to the non-conductive film carrier of the base material. Next, a second copper foil is placed on the adhesive layer. Thereafter, all of the layers are laminated. This is followed by the formation of through-holes in the area surrounding the bending area while circuit patterns are formed in the flexible or bending area (the registration holes again providing assistance in positioning). The spaces between the circuit pattern, as well as the entire copper foil, is then etched away in the bending area, and, finally, all the conducting path areas are covered with non-conductive cover film. As a result, the conducting paths are located in the "neutral section", that is, the area of the flexible circuit board which is neutral with respect to the forces generated during bending.
Patent NO-862123-L (NO)
Inventor: LIPINSKI CHRISTOPHER ANDREW
IPC: C07D471/10
Filed: 1986-05-28
Abstract: Spiro-imidazolidines of the formula: 
<CHEM>
 and the pharmaceutically acceptable salts thereof, wherein X is O, CH2 or NH; R is hydrogen, fluoro, chloro, methyl or methoxy; and Y is O or CH2. 
<??>These compounds are useful in treatment to prevent or alleviate ocular or neuritic diabetes-associated chronic complications.
Patent NO-873131-L (NO)
Inventor: KLUGE ARTHUR F
IPC: C07C47/267
Filed: 1987-07-27
Abstract: Compounds useful in treating cardiovascular disorders such as thrombosis, hypertension, and atherosclerosis and in inhibiting gastric acid secretion are compounds depicted in formulas (1), (2), and (3): <CHEM>  wherein:  Y is exo-(lower alkyl) or endo-(lower alkyl);  n is 2 or 3;  R1 is CH2OH, CHO, CO2R or CO2H;  R2 is hydrogen or methyl; and  R3 is linear or branched alkyl having 5-10 carbon atoms, <CHEM> optionally substituted with lower alkyl, lower alkoxy, trifluoromethyl, or halogen,  in which  a is 0, 1 or 2;  b is 3-7;  m is 1 or 2; and  R is <CHEM>  wherein X is <CHEM> in which each R4 is independently hydrogen or lower alkyl having 1-6 carbon atoms, and the pharmaceutically acceptable, non-toxic salts and esters thereof.
Patent NO-891675-L (NO)
Inventor: JONES MICHAEL EDWARD BENET
IPC: A61F2/32
Filed: 1989-04-24
Abstract: A prosthetic device prepared by curing an intimate mixture of an addition-polymerisable composition and a particulate inorganic solid which provides up to 80% by volume of the prosthetic device. The prosthetic device has a flexural modulus similar to the boney tissue which it contacts in use.